You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Vela purchased Great Basin for $1.4 million in June, and will reopen its Utah-based lab, rehire employees, and commercialize the firm's infectious disease platform.
The South Korean company said the kit not only detects Zika, but is also set up to find multiple mosquito-borne diseases such as Dengue and Chikunguya.
Under the agreement, Lucigen will use the CleanAmp dNTPs in its Taq98 Hot Start 2X MasterMix.
TriLink hopes that these modifications will provide the same benefit as hot-start approaches for PCR; namely, a substantial improvement in specificity and performance compared to conventional LCR.
Meridian Bioscience's acquisition of Bioline both provides Meridian a foothold in the PCR market and is expected to help drive future diagnostic development at the company.
The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.
NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.
Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.
In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.